Wells Fargo’s Genesis Healthcare, Inc. GEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-405
| Closed | – | – | 7728 |
|
|
2020
Q4 | $0 | Sell |
405
-95,943
| -100% | -$48.5K | ﹤0.01% | 7361 |
|
|
2020
Q3 | $52K | Sell |
96,348
-10,933
| -10% | -$7.86K | ﹤0.01% | 5501 |
|
|
2020
Q2 | $74K | Sell |
107,281
-46,460
| -30% | -$37.4K | ﹤0.01% | 5356 |
|
|
2020
Q1 | $129K | Buy |
153,741
+15,674
| +11% | +$22.4K | ﹤0.01% | 4936 |
|
|
2019
Q4 | $227K | Buy |
138,067
+110,051
| +393% | +$165K | ﹤0.01% | 4873 |
|
|
2019
Q3 | $32K | Sell |
28,016
-864
| -3% | -$999 | ﹤0.01% | 5689 |
|
|
2019
Q2 | $36K | Sell |
28,880
-6,751
| -19% | -$8.6K | ﹤0.01% | 5658 |
|
|
2019
Q1 | $51K | Buy |
35,631
+4,135
| +13% | +$6.13K | ﹤0.01% | 5314 |
|
|
2018
Q4 | $37K | Buy |
31,496
+161
| +0.5% | +$239 | ﹤0.01% | 5618 |
|
|
2018
Q3 | $42K | Sell |
31,335
-1,681
| -5% | -$2.66K | ﹤0.01% | 5646 |
|
|
2018
Q2 | $76K | Sell |
33,016
-192
| -0.6% | -$371 | ﹤0.01% | 5482 |
|
|
2018
Q1 | $51K | Sell |
33,208
-126
| -0.4% | -$148 | ﹤0.01% | 5558 |
|
|
2017
Q4 | $25K | Sell |
33,334
-54,671
| -62% | -$48.9K | ﹤0.01% | 5738 |
|
|
2017
Q3 | $102K | Buy |
88,005
+42,676
| +94% | +$53.8K | ﹤0.01% | 5230 |
|
|
2017
Q2 | $80K | Sell |
45,329
-94,722
| -68% | -$201K | ﹤0.01% | 5262 |
|
|
2017
Q1 | $370K | Sell |
140,051
-84,830
| -38% | -$305K | ﹤0.01% | 4444 |
|
|
2016
Q4 | $956K | Buy |
224,881
+194,180
| +632% | +$640K | ﹤0.01% | 3732 |
|
|
2016
Q3 | $82K | Buy |
30,701
+18,915
| +160% | +$43.5K | ﹤0.01% | 5033 |
|
|
2016
Q2 | $21K | Sell |
11,786
-3,973
| -25% | -$8.11K | ﹤0.01% | 5485 |
|
|
2016
Q1 | $37K | Buy |
15,759
+3,786
| +32% | +$8.56K | ﹤0.01% | 5330 |
|
|
2015
Q4 | $41K | Sell |
11,973
-1,590
| -12% | -$7.61K | ﹤0.01% | 5359 |
|
|
2015
Q3 | $83K | Buy |
13,563
+1,442
| +12% | +$9.78K | ﹤0.01% | 5020 |
|
|
2015
Q2 | $80K | Sell |
12,121
-30,715
| -72% | -$207K | ﹤0.01% | 5176 |
|
|
2015
Q1 | $304K | Buy |
+42,836
| New | +$323K | ﹤0.01% | 4212 |
|
Other funds holding GEN
IC
TRCT
Wells Fargo's GEN Position: Q1 2021 in Review
Wells Fargo sold out of Genesis Healthcare, Inc. (GEN) in Q1 2021, closing a stake of 405 shares.
Wells Fargo first reported a position in GEN in Q1 2015 and held it in 24 quarters. The position peaked at $956K in Q4 2016. 8 funds tracked by Wall St. Rank hold GEN as of Q1 2021.
- Wells Fargo reported no remaining Genesis Healthcare, Inc. position as of Q1 2021 after selling out during the quarter.
- Wells Fargo sold 405 Genesis Healthcare, Inc. shares in Q1 2021.
- Wells Fargo first reported a position in Genesis Healthcare, Inc. in Q1 2015 and held it in 24 quarters.
- Wells Fargo's Genesis Healthcare, Inc. position peaked at $956K in Q4 2016.
- 8 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q1 2021.
Based on Wells Fargo's 13F filing for Q1 2021, filed 13 May 2021.